Effects of a Novel Histone Deacetylase Inhibitor, N-(2-Aminophenyl) Benzamide, on a Reversible Hypertrophy Induced by Isoproterenol in In Situ Rat Hearts
The aim of the present study was performed to determine whether a novel histone deacetylase (HDAC) inhibitor, N-(2-aminophenyl)-4-{[benzyl(2-hydroxyethyl)amino]methyl} benzamide (K-183), prevents a reversible cardiac hypertrophy induced by isoproterenol and improves left ventricular (LV) dysfunction...
Main Authors: | Yutaka Kitagawa, Yamato Tamura, Juichiro Shimizu, Chikako Nakajima-Takenaka, Shigeki Taniguchi, Shinichi Uesato, Miyako Takaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2007-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319342665 |
Similar Items
-
Discovery of N-(2-Aminophenyl)-4-(bis(2-chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor
by: Lihui Zhang, et al.
Published: (2019-08-01) -
Roles and Targets of Class I and IIa Histone Deacetylases in Cardiac Hypertrophy
by: Hae Jin Kee, et al.
Published: (2011-01-01) -
Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats
by: Songjukta Chakraborty, et al.
Published: (2015-01-01) -
Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy
by: Harold Ray Garner, et al.
Published: (2010-02-01) -
<i>In Vitro</i> Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi)
by: Annabelle Friedrich, et al.
Published: (2020-07-01)